tiprankstipranks
Trending News
More News >
Xenon Pharmaceuticals: Undervalued Stock with Promising Catalysts and Growth Potential
PremiumRatingsXenon Pharmaceuticals: Undervalued Stock with Promising Catalysts and Growth Potential
24d ago
Xenon Pharmaceuticals to Present Promising Azetukalner Data at AAN 2025
Premium
Company Announcements
Xenon Pharmaceuticals to Present Promising Azetukalner Data at AAN 2025
1M ago
Xenon’s Growth Potential and Stability: A Buy Rating Supported by Financial Strength and Strategic Initiatives
Premium
Ratings
Xenon’s Growth Potential and Stability: A Buy Rating Supported by Financial Strength and Strategic Initiatives
2M ago
Xenon Pharmaceuticals price target lowered to $42 from $43 at Wedbush
PremiumThe FlyXenon Pharmaceuticals price target lowered to $42 from $43 at Wedbush
2M ago
Xenon Pharmaceuticals price target raised to $58 from $56 at RBC Capital
Premium
The Fly
Xenon Pharmaceuticals price target raised to $58 from $56 at RBC Capital
2M ago
Promising Prospects for Xenon: Buy Rating Backed by Azetukalner’s Versatility and Strong Clinical Data
Premium
Ratings
Promising Prospects for Xenon: Buy Rating Backed by Azetukalner’s Versatility and Strong Clinical Data
2M ago
Xenon Pharmaceuticals to Present at TD Cowen Healthcare Conference
PremiumCompany AnnouncementsXenon Pharmaceuticals to Present at TD Cowen Healthcare Conference
2M ago
Xenon Pharmaceuticals (XENE) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Xenon Pharmaceuticals (XENE) Q4 Earnings Cheat Sheet
2M ago
Xenon’s Strategic Pipeline Expansion and R&D Investments Drive Buy Rating Amid Neurology Sector Opportunities
Premium
Ratings
Xenon’s Strategic Pipeline Expansion and R&D Investments Drive Buy Rating Amid Neurology Sector Opportunities
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100